3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Endocrine
2
CNS
2
Other solid neoplasm
1
NET
1
Head & Neck
1
Genitourinary
1
Breast
1
Conditions
Pheochromocytoma
1
Paraganglioma
1
Neuroendocrine Tumors
1
Interventions
telotristat ethyl
3
lutetium Lu 177 dotatate
3
3-Iodobenzylguanidine
3
177Lu-octreotide, DOTA(0)-Tyr(3)-
2
veliparib
1
vandetanib
1
pasireotide
1
gallium Ga 68 dotatate
1
Tretinoin
1
Temozolomide
1
Isotretinoin
1
Introns
1
Everolimus
1
Diazoxide
1
Capecitabine
1
177Lu-octreotate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
vandetanib
×
NET
×
Clear all
NCT01941849
2015-12-21
VIBRaNT
University College, London
Phase 1
Withdrawn